TRANSPEKCommodity Chemicals
Transpek Inds — Profit & Loss Statement
₹1392.00
+0.00%
Transpek Inds Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | -0.70 Cr | 0.13 Cr | — |
| Tax Rate For Calcs | 0.21 | 0.31 | 0.26 | 0.22 | — |
| Normalized EBITDA | 123.39 Cr | 107.46 Cr | 163.91 Cr | 120.69 Cr | — |
| Total Unusual Items | 0.00 | 0.00 | -2.69 Cr | 0.59 Cr | — |
| Total Unusual Items Excluding Goodwill | 0.00 | 0.00 | -2.69 Cr | 0.59 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 48.74 Cr | 38.56 Cr | 83.48 Cr | 65.40 Cr | — |
| Reconciled Depreciation | 49.99 Cr | 37.60 Cr | 33.02 Cr | 29.73 Cr | — |
| Reconciled Cost Of Revenue | 332.46 Cr | 287.41 Cr | 447.67 Cr | 321.90 Cr | — |
| EBITDA | 123.39 Cr | 107.46 Cr | 161.23 Cr | 121.28 Cr | — |
| EBIT | 73.40 Cr | 69.87 Cr | 128.21 Cr | 91.55 Cr | — |
| Net Interest Income | -11.74 Cr | -14.35 Cr | -17.62 Cr | -8.96 Cr | — |
| Interest Expense | 11.74 Cr | 14.35 Cr | 15.41 Cr | 7.31 Cr | — |
| Normalized Income | 48.74 Cr | 38.56 Cr | 85.46 Cr | 64.94 Cr | — |
| Net Income From Continuing And Discontinued Operation | 48.74 Cr | 38.56 Cr | 83.48 Cr | 65.40 Cr | — |
| Total Expenses | 605.16 Cr | 534.92 Cr | 694.77 Cr | 521.44 Cr | — |
| Diluted Average Shares | 0.56 Cr | 0.56 Cr | 0.56 Cr | 0.56 Cr | — |
| Basic Average Shares | 0.56 Cr | 0.56 Cr | 0.56 Cr | 0.56 Cr | — |
| Diluted EPS | 87.25 | 69.03 | 149.45 | 117.09 | — |
| Basic EPS | 87.25 | 69.03 | 149.45 | 117.09 | — |
| Diluted NI Availto Com Stockholders | 48.74 Cr | 38.56 Cr | 83.48 Cr | 65.40 Cr | — |
| Net Income Common Stockholders | 48.74 Cr | 38.56 Cr | 83.48 Cr | 65.40 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 48.74 Cr | 38.56 Cr | 83.48 Cr | 65.40 Cr | — |
| Net Income Including Noncontrolling Interests | 48.74 Cr | 38.56 Cr | 83.48 Cr | 65.40 Cr | — |
| Net Income Continuous Operations | 48.74 Cr | 38.56 Cr | 83.48 Cr | 65.40 Cr | — |
| Tax Provision | 12.92 Cr | 16.95 Cr | 29.32 Cr | 18.84 Cr | — |
| Pretax Income | 61.66 Cr | 55.51 Cr | 112.80 Cr | 84.24 Cr | — |
| Other Non Operating Income Expenses | 28.71 Cr | 25.16 Cr | 8.13 Cr | 8.10 Cr | — |
| Special Income Charges | 0.00 | 0.00 | -2.69 Cr | 0.59 Cr | — |
| Net Non Operating Interest Income Expense | -11.74 Cr | -14.35 Cr | -17.62 Cr | -8.96 Cr | — |
| Interest Expense Non Operating | 11.74 Cr | 14.35 Cr | 15.41 Cr | 7.31 Cr | — |
| Operating Income | 44.69 Cr | 44.71 Cr | 130.88 Cr | 76.84 Cr | — |
| Operating Expense | 272.70 Cr | 247.51 Cr | 247.10 Cr | 199.54 Cr | — |
| Other Operating Expenses | 156.08 Cr | 148.33 Cr | 85.14 Cr | 72.04 Cr | — |
| Depreciation And Amortization In Income Statement | 49.99 Cr | 37.60 Cr | 33.02 Cr | 29.73 Cr | — |
| Depreciation Income Statement | 49.99 Cr | 37.60 Cr | 33.02 Cr | 29.73 Cr | — |
| Gross Profit | 317.39 Cr | 292.22 Cr | 377.98 Cr | 276.39 Cr | — |
| Cost Of Revenue | 332.46 Cr | 287.41 Cr | 447.67 Cr | 321.90 Cr | — |
| Total Revenue | 649.85 Cr | 579.63 Cr | 825.65 Cr | 598.28 Cr | — |
| Operating Revenue | 649.85 Cr | 579.63 Cr | 825.65 Cr | 598.28 Cr | — |
| Interest Income | — | 3.38 Cr | 1.61 Cr | 1.58 Cr | 0.61 Cr |
| Rent Expense Supplemental | — | 0.09 Cr | 0.08 Cr | 0.06 Cr | 0.15 Cr |
| Other Special Charges | — | -0.64 Cr | 2.69 Cr | -0.59 Cr | -1.70 Cr |
| Total Other Finance Cost | — | 2.45 Cr | 3.82 Cr | 3.23 Cr | 1.90 Cr |
| Interest Income Non Operating | — | 3.38 Cr | 1.61 Cr | 1.58 Cr | 0.61 Cr |
| Amortization | — | 9000.00 | — | — | — |
| Research And Development | — | 1.43 Cr | 1.52 Cr | 1.17 Cr | 0.90 Cr |
| Selling General And Administration | — | 53.94 Cr | 73.67 Cr | 49.41 Cr | 23.96 Cr |
| Selling And Marketing Expense | — | 47.26 Cr | 66.95 Cr | 43.22 Cr | 18.15 Cr |
| General And Administrative Expense | — | 6.68 Cr | 6.73 Cr | 6.19 Cr | 5.81 Cr |
| Rent And Landing Fees | — | 0.09 Cr | 0.08 Cr | 0.06 Cr | 0.15 Cr |
| Write Off | — | — | 0.00 | -2000.00 | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Transpek Inds
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.